Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
IASLC WCLC 2026
2026 ASCO GI
ASCO Breakthrough 2026
ASCO 2026
ESTRO 2026
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
Error loading Partial View script (file: ~/Views/MacroPartials/TAP List Meeting Articles.cshtml)
Advertisement
Advertisement
Sep
03
Today In Oncology
Prostate Cancer NRG-GU005 Defines Trade-Offs Between SBRT and Moderately Hypofractionated IMRT
ADC/Immunotherapy Combination Shows Activity in Treatment-Resistant Nasopharyngeal Carcinoma
Hypofractionated Salvage Radiotherapy Evaluated After Prostatectomy for Biochemical Recurrence
Dual Oral Regimen Shows Encouraging Activity in KRAS G12C–Mutated Metastatic Colorectal Cancer
Researchers Define Molecular Prognostic Subgroups in Therapy-Related Myeloid Neoplasms
View More
Advertisement
